| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 6, Issue 8 915-925, Copyright © 1995 by American Association of Cancer Research
ARTICLES |
ST Eblen, MP Fautsch, RA Anders and EB Leof
Department of Cell Biology, Vanderbilt University, Nashville, Tennessee, USA.
Mammalian cultures primarily regulate cell cycle traverse during G1. For progression through G1 and commitment to DNA synthesis, the activity of a family of proteins, the cyclin-dependent kinases (cdks), is required. There are two primary regulatory portions of G1: (a) the G0-G1 transition, which allows entry into G1; and (b) the G1-S transition, promoting entry to DNA synthesis and commitment to cell division. In the present manuscript, we provide evidence for cross-talk between these two cell cycle transitions. Extracts prepared from quiescent mouse mammary epithelial cells are shown to act in a dominant manner to specifically inhibit the histone H1 kinase activity of preformed/active cdk2, cdk4, cyclin A, or cyclin E complexes from G1-S cell extracts. The inhibitory activity arises as cells enter quiescence and decreases once cultures are stimulated to begin G1 traverse and endogenous cdk activity becomes evident. This activity is associated with the regulated binding of the cdk inhibitor p27Kip1 to cyclin A/cdk2 kinase complexes upon mixing of the extracts. Removal of p27Kip1 from the quiescent cell extract specifically abolishes the inhibitory effect. The inhibitory activity and p27Kip1 binding in vitro depend on incubation of the extracts at physiological temperature or the presence of a reducing agent. The results suggest an interplay between the acquisition of quiescence, cdk activity, and G1 traverse.
This article has been cited by other articles:
![]() |
Y. Ma, C. A. Kurtyka, S. Boyapalle, S.-S. Sung, H. Lawrence, W. Guida, and W. D. Cress A Small-Molecule E2F Inhibitor Blocks Growth in a Melanoma Culture Model Cancer Res., August 1, 2008; 68(15): 6292 - 6299. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. He and W. D. Cress E2F-3B Is a Physiological Target of Cyclin A J. Biol. Chem., June 21, 2002; 277(26): 23493 - 23499. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Frost, S. Delikat, S. Al-Mehairi, and A. J. Sinclair Regulation of p27KIP1 in Epstein-Barr virus-immortalized lymphoblastoid cell lines involves non-apoptotic caspase cleavage J. Gen. Virol., December 1, 2001; 82(12): 3057 - 3066. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Teixeira and M. A. C. Pratt CDK2 Is a Target for Retinoic Acid-Mediated Growth Inhibition in MCF-7 Human Breast Cancer Cells Mol. Endocrinol., August 1, 1997; 11(9): 1191 - 1202. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |